D-Pharm Receives Agreement Letter On Special Protocol Assessment For DP-b99 Study – A Pivotal Phase III Trial In Acute …
April 20, 2010 by biotechcheck.com · Leave a Comment
D-Pharm Receives Agreement Letter On Special Protocol Assessment For DP-b99 Study – A Pivotal Phase III Trial In Acute …
D-Pharm Ltd (DPRM: TASE) announced that it has reached an agreement with the U.S. Food and Drug Administration (FDA) under the Special Protocol Assessment (SPA) procedure for a pivotal phase 3 trial (MACSI) of its neuroprotective agent DP-b99 in acute ischemic stroke patients. The SPA agreement letter indicates that “the design and planned analysis of the study adequately address the objectives …
Read more on Medical News Today
PhytoMedical Signs a Letter of Intent (LOI) with a Leading Chinese Research Services Organization to Advance Brain …
April 18, 2010 by biotechcheck.com · Leave a Comment
PhytoMedical Signs a Letter of Intent (LOI) with a Leading Chinese Research Services Organization to Advance Brain …
PRINCETON, N.J.—-PhytoMedical Technologies, Inc. , a developer of ‘D11B’, an anti-cancer compound shown in primeval studies to inhibit the growth of difficult-to-treat brain cancer, this day announced that the Company has entered into a Letter of Intent with Shanghai Medicilon, Inc.
Read more on Business Wire via Yahoo! Finance
Video: Pope’s Letter Deepens Scandal
April 11, 2010 by biotechcheck.com · Leave a Comment
Video: Pope’s Letter Deepens Scandal
The Catholic Church scandal has drawn closer to Pope Benedict XVI, as a newly-released letter shows that he did tiny to defrock a priest convicted of sexually abusing minors. Ben Tracy reports.
Read more on CBS News
